Effect Of Chlordiazepoxide Oral Tablet On Oral Recurrent Bruxism, A Clinical Trial Human Study

Ghadah Ali Al-Oudah, A. Al-Ameedee, Ali Ameer Al-Ameedee
{"title":"Effect Of Chlordiazepoxide Oral Tablet On Oral Recurrent Bruxism, A Clinical Trial Human Study","authors":"Ghadah Ali Al-Oudah, A. Al-Ameedee, Ali Ameer Al-Ameedee","doi":"10.31838/SRP.2021.1.128","DOIUrl":null,"url":null,"abstract":"Background: Oral recurrent bruxism is the most common disease of the oral cavity. The underlying etiology remains unclear, and no curative treatment is available. Chlordiazepoxide is essential and useful as anti-anxiety, sedative, appetite-stimulating and weak analgesic actions substance, which recent evidence indicates its involved in emotional responses. Objectives: The present study aimed to use systemic drug such as Chlordiazepoxide oral tablet (5mg). Illnesses related to the oral bruxism by studying its effects in oral recurrent bruxism, this systemic therapy is not indicated in such situation among other drugs. Methods: In this study patients presented with oral recurrent bruxism were treated with Chlordiazepoxide oral tablet (5mg) administered orally once daily after night meal . The dispersible tablet was administered orally once daily for 10 days, 66 participants, 7 were excluded due to incomplete records (51 males and 8 females aged 45.0±6 years) with oral recurrent bruxism, divided into two groups; group A, 30 patients were randomly assigned to receive Chlordiazepoxide oral tablet (5mg) once per day at night, and group B; 29 patients with oral placebo daily for 10 days. Results: The results showed that administering of Chlordiazepoxide oral tablet (5mg) accelerated the healing process within a short time period (10 days) without complications or disfigurement in all patients. Group A, 24 patients, (the healing rate were 0.79%) of 30 patients were used Chlordiazepoxide oral tablet (5mg) doses administered orally had complete healing of oral recurrent bruxism at period time eight days of enzyme‑linked immunosorbent assay investigation. Also there will be a decline both in salivary cortisol and salivary alpha-amylase (sAA)levels during the time period of the study, compared with group B, only 6 patients (the healing rate were 0.21%) of 29 placebo-randomized patients. Conclusion: In this study showed that, the Chlordiazepoxide oral tablet treatment was effective in healing the oral recurrent bruxism and the end-points of the study were complete healing and absence of any discomfort pain while eating within a short period of treatment.","PeriodicalId":22121,"journal":{"name":"Systematic Reviews in Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Systematic Reviews in Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31838/SRP.2021.1.128","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Oral recurrent bruxism is the most common disease of the oral cavity. The underlying etiology remains unclear, and no curative treatment is available. Chlordiazepoxide is essential and useful as anti-anxiety, sedative, appetite-stimulating and weak analgesic actions substance, which recent evidence indicates its involved in emotional responses. Objectives: The present study aimed to use systemic drug such as Chlordiazepoxide oral tablet (5mg). Illnesses related to the oral bruxism by studying its effects in oral recurrent bruxism, this systemic therapy is not indicated in such situation among other drugs. Methods: In this study patients presented with oral recurrent bruxism were treated with Chlordiazepoxide oral tablet (5mg) administered orally once daily after night meal . The dispersible tablet was administered orally once daily for 10 days, 66 participants, 7 were excluded due to incomplete records (51 males and 8 females aged 45.0±6 years) with oral recurrent bruxism, divided into two groups; group A, 30 patients were randomly assigned to receive Chlordiazepoxide oral tablet (5mg) once per day at night, and group B; 29 patients with oral placebo daily for 10 days. Results: The results showed that administering of Chlordiazepoxide oral tablet (5mg) accelerated the healing process within a short time period (10 days) without complications or disfigurement in all patients. Group A, 24 patients, (the healing rate were 0.79%) of 30 patients were used Chlordiazepoxide oral tablet (5mg) doses administered orally had complete healing of oral recurrent bruxism at period time eight days of enzyme‑linked immunosorbent assay investigation. Also there will be a decline both in salivary cortisol and salivary alpha-amylase (sAA)levels during the time period of the study, compared with group B, only 6 patients (the healing rate were 0.21%) of 29 placebo-randomized patients. Conclusion: In this study showed that, the Chlordiazepoxide oral tablet treatment was effective in healing the oral recurrent bruxism and the end-points of the study were complete healing and absence of any discomfort pain while eating within a short period of treatment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
氯二氮环氧酯口服片治疗口腔复发性磨牙症的临床研究
背景:口腔复发性磨牙是口腔最常见的疾病。潜在的病因尚不清楚,也没有有效的治疗方法。氯二氮环氧化物作为抗焦虑、镇静、刺激食欲和弱镇痛作用物质是必需和有用的,最近的证据表明其参与情绪反应。目的:本研究旨在采用全身用药,如氯二氮环氧酯口服片(5mg)。通过研究与口腔磨牙相关的疾病对口腔复发性磨牙的影响,这种全身治疗方法在其他药物中并不适用于这种情况。方法:对口腔复发性磨牙患者给予氯二氮环氧酯口服片(5mg)治疗,每日1次,餐后口服。分散片每日口服1次,连续用药10 d, 66例口腔复发磨牙患者,其中7例因记录不完整而被排除(男51例,女8例,年龄45.0±6岁),分为两组;A组30例患者,随机分配给予氯二氮环氧化物口服片(5mg),每天1次,每晚1次;29名患者每天口服安慰剂,持续10天。结果:氯二氮环氧酯口服片(5mg)在短时间内(10天)加速愈合过程,无并发症和毁容。A组24例患者(治愈率为0.79%)30例患者采用氯二氮环氧酯口服片(5mg)口服给药,经8天酶联免疫吸附法调查口腔复发性磨牙完全愈合。在研究期间,唾液皮质醇和唾液α -淀粉酶(sAA)水平也会下降,与B组相比,29例安慰剂随机患者中只有6例患者(治愈率为0.21%)。结论:本研究表明氯二氮环氧酯口服片治疗口腔复发性磨牙是有效的,研究的终点是在短时间内治疗时完全愈合且无任何进食不适疼痛。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
New UV Curable Acrylated Urethane-Oligoesters Derived From Poly(Ethylene Terephthalate) PET Waste Effects of Terminalia chebula Retz. on the Secretion of Somatostatin in the Small Intestine in Mice Analysis of Level of Antioxidants and Oxidative Stress in Diabetic Patients Metabolomics Of Metformin's Cardioprotective Effect In Acute Doxorubicin Induced- Cardiotoxicity In Rats Cases of Adolescent Sudden Cardiac Death During Physical Exercise: Autopsy, Histological Findings
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1